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Abstract
Background: Statistics regarding HPV prevalence and cervical cancer rates in rural China are high, however, low
levels of HPV awareness and HPV-related knowledge pose a great challenge for cervical cancer control.
Methods: The authors conducted an educational intervention study, which was embedded in a cervical cancer
screening project in Yangcheng county, Shanxi Province, China from October to December, 2011 and was designed
to assess the short-term effectiveness of a hospital-based, brief, HPV-focused session on rural Chinese women’s
knowledge and attitudes. Student’s t-test was used when comparing quantitative variables. Chi-squared test or
Fisher’s exact tests was used when comparing qualitative variables.
Results: We found that following the intervention, significant increases were detected in awareness regarding HPV
(5.9 % vs. 59 %, p < 0.001) and cervical cancer (63.0 % vs. 89.2 %, p < 0.001). Changes were also observed
regarding women’s intention to vaccinate themselves (82.0 % vs. 89.0 %, p = 0.001) and their daughters
(82.9 % vs. 88.0 %, p = 0.011), although the impact was more modest compared with the impact on change
of awareness. Among women who were aware of HPV, 60.3 % knew that cervical cancer is related to HPV,
while only 5.0 % knew the relationship between HPV and genital warts after the educational intervention.
Conclusions: Educational campaigns, particularly those targeting women with limited education and poor
access to public media or other educational channels are needed to improve knowledge regarding HPV in
the general population.
Keywords: HPV awareness, Knowledge, Chinese women, Vaccine, Educational intervention, Change
Background
Shanxi province locates at the west of Taihang Mountains,
with 11 prefecture-level cities, 23 municipal districts, 11
county-level cities and 85 counties. By the end of 2012,
the registered permanent resident population of Shanxi
province had reached 36.1 million. Yangcheng county lo-
cates at the southeast of Shanxi province, with approxi-
mately 0.4 million population, of which nearly 60 % live in
the rural areas [1]. It is reported that Yangcheng county
suffers high cervical cancer incidence (81.0 /105) [2] and
mortality (11.2/105) [3] due to lack of education, poverty,
and inability to pay for health care [4]. A pooled analysis
also suggested that rural women were more than twofold
likely to be infected by high risk HPV than urban women
in China [5]. With an estimated 500 million women in
rural China, the public health challenge to prevent cervical
cancer is substantial. The Chinese government has put the
health of rural women firmly on their domestic agenda.
From 2009 to 2011, free cervical cancer screening exami-
nations were made accessible to 10 million rural Chinese
women [6].
Studies have clearly illustrated that lack of knowledge
about HPV and low levels of understanding of HPV
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vaccination have direct implications for women’s partici-
pation in cervical screening [7, 8]. Despite this, the im-
portance of health education as an integral part of
primary prevention for cervical cancer is often ignored
[9]. Resources focused on educational campaigns to in-
crease women’s knowledge and awareness of HPV and its
vaccines may impact the success of screening programs.
A previous multi-center cross-sectional study reported
that only 15.5 % of women interviewed reported to have
ever heard of HPV in China. And the proportion among
rural women was only 9.3 % [10]. The study also found
that hospital based lectures and suggestions from doc-
tors and nurses played a significant role in influencing
decisions about being vaccinated.
As no previous study has been conducted to evaluate
a way of changing the ‘low HPV awareness’ in China,
our study sought to assess the short-term effectiveness
of a hospital-based, local health provider oriented educa-
tional intervention on rural women’s knowledge and at-
titudes towards the prevention of cervical cancer and
HPV infection immediately following the group educa-
tion as an intervention.
If this intervention approves to be effective in raising
the awareness of HPV and cervical cancer prevention
among women, an increased attendance to cervical can-
cer screening might be achieved when such education is
widely disseminated especially through the existed edu-
cational system led by China CDC. Also, it might help
enhance the HPV vaccination uptake among Chinese
women in the future when HPV vaccines become
available.
Methods
Study design and population
This study was a questionnaire-based, cross-sectional
study conducted from October to December, 2011, and
it was embedded in a project called “the Low-Cost Mo-
lecular Cervical Cancer Screening Study (LCMCCSS)”
and was funded by the Bill & Melinda Gates Foundation.
It was conducted collaboratively by Program for Appro-
priate Technology in Health (PATH) and the Cancer In-
stitute of the Chinese Academy of Medical Sciences
(CICAMS) after approval by the Institutional Review
Boards of both organizations.
Stratified randomized cluster sampling was used in
one of the cervical cancer high-risk provinces of China,
Shanxi province. Initially, a cervical cancer high-risk
county from Shanxi, the Yangcheng county, was selected.
Two high risk communities (Baisang Xiang and Ding-
dian Town) from Yangcheng county were then targeted
based on the estimated numbers of women registered on
the Shanxi permanent residency registry. Twenty-two
villages as clusters were then randomly selected from a
total of 38 villages to achieve a target population of
3,000. All non-pregnant women aged 25–65 years with-
out a history of Cervical Intraepithelial Neoplasia (CIN),
cervical cancer, or hysterectomy and who were mentally
and physically competent to provide written informed
consent were eligible for the ‘LCMCCSS’ screening study
regardless of their marital status.
Among the 22 villages that were targeted for cervical
cancer screening, 8 as clusters were randomly selected
for an extra educational intervention. Among women
from the 8 villages, those who had an even last digit in
their randomly allocated study ID were invited to attend
our educational intervention study (Fig. 1).
Participant recruitment procedure
For the cervical cancer screening study: All recruitment
was done by village doctors. They were trained by inves-
tigators from CICAMS prior to the initiation of the
study. After the training, a list of targeted women and
their basic information (e.g. age, living address, contact)
was provided by the local permanent resident registra-
tion system. The trained village doctors then dropped
house-to-house visits to women according to the list.
During the house visits, the inclusion and exclusion cri-
teria as well as the potential benefits and risks were
clearly explained to women. For those who verbally
agreed to participate, village doctors made a screening
appointment for them.
For the educational intervention study: Recruitment
was done on the same day when women attending cer-
vical cancer screening at the screening site (the local
hospital) by investigators from CICAMS. Free transpor-
tation and cervical cancer screening were offered to
women who were willing to participate in the educa-
tional intervention study.
Informed consent
Women who were willing to attend the educational
intervention study provided informed consents on a vol-
untary basis. During the process, the words ‘HPV’ and
‘cervical cancer’ were not mentioned in order to avoid
possible contaminations to the educational intervention.
Instead, women were carefully explained by the investi-
gators that they would be asked about some facts of an
organ-specific female cancer, its etiology and methods to
prevention. Questions would be asked both before and
after a PowerPoint (PPT) oriented health education by
trained interviewers.
Pre-intervention HPV questionnaire
Immediately after providing the informed consent par-
ticipants were administered a ‘Pre-intervention HPV
questionnaire’ in independent rooms by trained female
nurses aged 26–40 years. Questions on ①: Have you
ever heard of HPV? ②: Have you ever heard of cervical
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cancer? ③: Do you have daughter (s)? ④: If prophylactic
HPV vaccines were available, would you be willing to
vaccinate your daughter? ⑤: If prophylactic HPV vac-
cines are available, would you be willing to vaccinate
yourself? (only for women aged ≤ 45 years) were asked in
this section.
When asked, women only need to answer ‘Yes’ or
‘No’. The word ‘prophylactic’ was also explained to
women by the trained nurses in a very common sense
way. For example, it was explained as : if you get vacci-
nated, you will not been infected by some types of the
virus (HPV) that cause cervical cancer, like how HBV
vaccines work to prevent hepatitis B infection.
Group education
After administration of the ‘Pre-intervention HPV ques-
tionnaire’, women were convened in a meeting room in
the hospital and an educational lecture was provided by
a trained local doctor in local dialect by using a stan-
dardized PPT. During the lecture, women were taught
basic concepts regarding ① What is cervical cancer, how
does it threaten women’s health and lives;② What is
HPV and its relation to cervical cancer;③ What kind of
screening tests are available for the secondary prevention
of cervical cancer;④ The current status of prophylactic
vaccines for the primary prevention from cervical can-
cer. The lecture was given to 25–30 women per time by
the same trained doctor, and lasted for about 40 min.
Two group educations were given each day, one was in
the morning and the other was in the afternoon.
Post-intervention HPV questionnaire
After the group education, it takes a short term
(about 5 min) to re-allocate women to the same interview
room and they were interviewed again by the same trained
nurses in a confidential setting about cervical cancer, HPV
and the related preventions. In addition to questions asked
in the pre-intervention questionnaire, more specific infor-
mation was collected using the pre-tested questionnaire
administered in the earlier study [8].
Fig. 1 Study population
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Other questionnaires and clinical procedures
Prior to the screening and after informed consent for
the screening study, the participants were administered
a risk factor questionnaire, which contained not only the
socio-demographics but also some risk factors related to
HPV infection and cervical cancer (e.g. age at sexual de-
but, No. of sexual partner (s) etc.). Women then re-
ceived gynecological examinations in the study clinic
situated in their residential district. Cervical and vaginal
specimens were collected by doctors from women
undergoing routine examinations.
Data collection and quality control
Two data input clerks in each site were recruited to
double-enter data from the paper to computer-based
database (FoxPro) independently after training. All fin-
ished double-entry databases were sent to CICAMS for
validation by running EpiData. Any inconsistency found
by CICAMS between the two databases was reported to
the local clerks for adjudication until the databases
agreed. As final check, one database was chosen and
underwent a final consistency check. Logic errors (e.g. a
woman reported had never heard of HPV yet knew the
link between HPV and cervical cancer) were again re-
ported back to the local sites, and the local collaborators
contacted the participants using the contact information
provided in the risk factor questionnaires. After checking
with the participants, the local staffs sent the revised
database back to CICAMS for final analysis. This pro-
cedure was strictly followed as previously described [10].
Statistical analyses
Basic descriptive statistics and frequency calculations
were performed on all demographic variables. Student’s
t-test was used when comparing quantitative variables.
Chi-squared test or Fisher’s exact tests was used when
comparing qualitative variables. SAS statistical software
version 9.1 (SAS Institute Inc., Cary, NC, USA) was used
to analyze the data. Statistical significance was assessed
by two-tailed tests with α level of 0.05.
Results
Participants profile
Of the 4,230 women that were recruited to attend the
cervical cancer screening, 3,241 women came with a
compliance of 80.9 %. Among them, 1,829 were from
the 8 villages selected for educational intervention.
Among the 1,829 women, 913 women with randomly al-
located even ID numbers were recruited to attend the
educational intervention study and all agreed.
The mean age of participants was 42.3 years (s.d. =8.7 years),
with the youngest of 25 years and the oldest of
64 years. All participants were ethnic Han. Table 1
reports the distribution of intervention and non-
intervention groups. Differences regarding the distri-
bution of age, education, occupation, alcohol drinking,
age at sexual debut, age at first pregnancy and No. of
live birth were seen between the two groups.
Most women (97.6 %) from the intervention group
were married and the majority (82.0 %) had only pri-
mary school or middle school education. Few women
smoked (0.1 %) or drank alcohol (7.3 %). Trichomo-
nas (11.2 %), fungal infection (9.8%), and urinary tract
infection (6.1 %) were the most common self-reported
previous genital infections. The average age of sexual
debut was 21.1 years (s.d. =1.8 years) and the age of
sexual debut for 43.4 % (n = 396) of participants was
22 years or older. Most women reported only having
one sexual partner in their lifetime (80.9 %). Most
women (69.0 %) had two or more live births. Com-
pared with the non-intervention group, the interven-
tion group had more women from younger age group
(25–34 years) and had a higher proportion of receiv-
ing middle school education (Table 1).
HPV awareness and attitudes about HPV vaccine before
education
Before the group education, very few (5.9 %) women re-
ported having ever heard of HPV. Women with >9 years
of education were significantly more likely (22.4 %) to
have heard of HPV than those with ≤9 years of educa-
tion (2.9 %) (P <0.001). Age did not influence women’s
awareness of HPV (Table 2). By contrast, 63.0 % of the
women in the study had heard of cervical cancer. Both
more educated women (>9 years) and younger women
(≤45 years) were more likely to be aware of cervical can-
cer (Table 2). The majority of women were willing to
vaccinate their daughter(s) (82.2 %) or themselves
(80.3 %) before education at baseline (Table 2).
HPV knowledge after education
After the group education, HPV awareness increased
to 59.0 % (539/913). Specific knowledge about the
risk of HPV, its link between cervical cancer etc. is
presented in Table 3. Among women who had ever
heard of HPV (n = 539), 60.3 % (365/539) knew that
HPV is related to cervical cancer with a higher pro-
portion (69.7 %) among more educated women com-
pared with less educated women (58.0 %). Younger
women (≤45 years) were more likely (65.7 %) to know
the relationship between HPV and cervical cancer
than women >45 years (47.2 %). Only 5.0 % (30/539)
of women knew that HPV is associated with genital
warts, with a higher proportion (8.2 %) among more
educated women compared with less educated women
(4.1 %), and no significant difference was observed
between the two age groups (Table 3).
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Among women who had ever heard of cervical cancer
(n = 814), 79.4 % (646/814) knew that cervical cancer is
early detectable and treatable. Knowledge rates were
higher among those with higher education level and
younger age (P <0.05) (Table 3).
Attitudes about HPV vaccines after education
Table 4 presents reasons for being willing and unwilling
to be vaccinated after education. The majority (88.8 %;
513/578) of participants were willing to be vaccinated.
Fear of getting cervical cancer without vaccination
Table 1 The distribution of sociodemographics of intervention and non-intervention participants (N = 913)
Variable Intervention group(N = 913) Non-Intervention group(N = 2,328) p
n % n %
Age(yrs) 25 ~ 34 171 18.7 304 13.0 <0.001
35 ~ 44 372 40.8 866 37.2
45 ~ 54 277 30.3 707 30.4
≥55 93 10.2 451 19.4
Marital status Married 891 97.6 2252 96.7 0.201
Single or others 22 2.4 76 3.3
Education Illiteracy 42 4.6 147 6.3 <0.001
Primary school 277 30.3 850 36.5
Middle school 472 51.7 1052 45.2
High school and above 122 13.4 279 12.0
Occupation Worker 30 3.3 40 1.7 0.003
Farmer 788 86.3 2105 90.4
White collar/Professionals 63 6.9 116 5.0
Others 32 3.5 67 2.9
Smoking history Never 912 99.9 2323 99.8 0.531
Ever/Current 1 0.1 5 0.2
Alcohol drinking history Never 846 92.7 2097 90.1 0.022
Occasionally or others 67 7.3 231 9.9
Disease History Trichomonas 102 11.2 257 11.1 0.914
Fungus infection 89 9.8 192 8.2 0.172
Urinary Tract Infection 56 6.1 184 7.9 0.083
Cervitics 10 1.1 96 4.1 <0.001
None 701 76.8 1740 74.7 0.226
Age at sexual debut (yrs) <20 139 15.2 453 19.4 0.013
20 179 19.6 488 21.0
21 199 21.8 484 20.8
≥22 396 43.4 903 38.8
No. of sexual partners 1 739 80.9 1948 83.7 0.059
2 141 15.5 287 12.3
≥3 33 3.6 93 4.0
Age at first pregnancy (yrs)a <21 179 19.8 512 22.2 0.005
21 133 14.7 433 18.8
22 184 20.3 444 19.2
≥23 409 45.2 919 39.8
No. of live birtha 0 8 0.9 12 0.5 0.005
1 273 30.1 577 25.0
≥2 624 69.0 1719 74.5
a905 women had pregnancy history among the intervention participants
Boldface reflects statistical significance
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(43.8 %; 322/513), benefits to themselves (26.9 %; 198/
513) and concern about having been infected with HPV
(21.9 %; 161/513) were the primary reasons for women
to be vaccinated. Education level did not change the rea-
sons for women to be vaccinated (Table 4). Doubts re-
garding the efficacy of HPV vaccine (34.3 %; 23/65) were
the major reason for unwillingness to get vaccinated,
and women with >9 years of education were more likely
to choose this as a reason (Table 4).
Six hundred and thirty six (69.7 %) women reported that
they had daughters. Among them, 88.1%(560/636) were
willing to vaccinate their daughters, 11.9 % (76/636) were
unwilling, mainly because they do not think their daugh-
ters are at risk (31.8 %; 26/76), followed by doubt regard-
ing the vaccine’s efficacy (28.2 %; 24/76). Education level
did not influence the reasons for willingness or unwilling-
ness to vaccinate their daughters (Table 4).
Effect of education on women’s awareness and attitudes
Table 5 presents the responses to questions related to
HPV and its vaccines before and after the group educa-
tion. When women were asked if they had ever heard of
HPV, a significant change (5.9 % vs. 59.0 %, P < 0.001) in
women’s awareness was observed following the educa-
tional intervention. When asked about their awareness
of cervical cancer, the proportion of ‘yes’ answers also
increased significantly (63.0 % v. 89.2 %, P < 0.001).
When questioned about their intention of being vacci-
nated or vaccinating their daughters, the proportion of
women with positive responses increased substantially.
Discussion
This study investigated rural Chinese women’s baseline
HPV knowledge and their attitudes toward HPV vaccines.
It is the first study in China to evaluate the short-term ef-
fectiveness of a hospital based group education to change
local women’s knowledge, beliefs and attitudes towards
the prevention of HPV infection and cervical cancer.
Based on the most recent WHO position paper on
HPV vaccines, the recommended primary target popula-
tion are young females of 9–13 years, and the secondary
target population are older adolescent females or young
women. There is no defined up limit of age been vacci-
nated [11]. In addition, there were two peaks of HPV in-
fection among Chinese women, one is around 20 years
and the other is around 45 years old [12]. It is particular
important to educate and try to understand the know-
ledge and attitudes of women in older age group, which
was covered by our study population. This may also con-
tributes to the future catch-up doses for elder women.
Results confirm that women living in rural China have
very limited awareness of HPV and its related diseases
Table 2 Women’s awareness and attitudes before intervention by education level and age
Item Years of Education Age
All ≤9 years >9 years ≤45 years >45 years
n (%) n (%) n (%) P n (%) n (%) P
Have you ever heard of HPV?(N = 913)
Yes 54 (5.9) 22 (2.9) 32 (22.4) <0.001b 40 (6.8) 14 (4.3) 0.114b
No 859 (94.1) 748 (97.1) 111 (77.6) 545 (93.2) 314 (95.7)
Total 913 770 143 585 328
Have you ever heard of cervical cancer?(N = 913)
Yes 575 (63.0) 445 (57.8) 130 (90.9) <0.001b 416 (71.1) 159 (48.5) <0.001b
No 338 (37.0) 325 (42.2) 13 (9.1) 169 (28.9) 169 (51.5)
Total 913 770 143 585 328
If there are prophylactic vaccines, are you willing to vaccinate your daughter?(N = 636*)
Yes 523 (82.2) 453 (81.5) 70 (87.5) 0.241b 323 (83.7) 200 (80.0) 0.229b
No 108 (17.0) 98 (17.6) 10 (12.5) 60 (15.5) 48 (19.2)
Missing 5 (0.8) 5 (0.9) 0 (0.0) 3 (0.8) 2 (0.8)
Total 636 556 80 386 250
If there are prophylactic vaccines, are your willing to vaccinate yourself?(N = 585**)
Yes 470 (80.3) 394 (79.6) 76 (84.5) 0.249b - - -
No 103 (17.6) 91 (18.4) 12 (13.3) - -
Missing 12 (2.1) 10 (2.0) 2 (2.2)
Total 585 495 90 - -
*Only answered by women with daughter(s) **Only answered by women aged ≤45 years
Boldface reflects statistical significance
bχ2 test
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Table 4 Women’s attitudes about HPV vaccines after intervention by education levels
Item To vaccinate themselves* To vaccinate their daughter (s)
All Education Education All Education Education
≤9 years >9 years ≤9 years >9 years
n (%) n (%) n (%) P n (%) n (%) n (%) P
(1)Reasons for willing to vaccinate themselves (n = 513) To vaccinate their daugher(s) (n = 560)
Can Benefit myself/my daughter(s) 198 (26.9) 153 (25.2) 45 (34.9) 0.110b 231 (28.6) 188 (27.2) 43 (36.4) 0.187c
Fear of HPV infection 161 (21.9) 132 (21.7) 29 (22.5) 187 (23.1) 160 (23.2) 27 (22.9)
Fear of having CC 322 (43.8) 276 (45.5) 46 (35.6) 334 (41.3) 296 (42.8) 38 (32.2)
Fear of having genital warts 51 (6.9) 42 (6.9) 9 (7.0) 55 (6.8) 45 (6.5) 10 (8.5)
Total 736 607 129 809 691 118
(2)Reasons for unwilling to vaccinate themselves(n = 65) To vaccinate their daugher(s)(n = 76)
I don’t have risk 19 (28.4) 17 (28.8) 2 (25.0) 0.004c 26 (31.8) 24 (32.9) 2 (20.0) 0.136c
Don’t think the vaccination works 23 (34.3) 23 (39.0) 0 (0.0) 24 (28.2) 23 (31.5) 1 (10.0)
It hasn’t been widely used 7 (10.4) 4 (6.8) 3 (37.5) 10 (11.8) 7 (9.6) 3 (30.0)
Vaccination causes risks 5 (7.5) 3 (5.1) 2 (25.0) 6 (7.1) 5 (6.8) 1 (10.0)
Doubts on the resource 7 (10.4) 7 (11.8) 0 (0.0) 6 (8.2) 4 (5.5) 2 (20.0)
No answer** 6 (9.0) 5 (8.5) 1 (12.5) 11 (12.9) 10 (13.7) 1 (10.0)
Total 67 59 8 83 73 10
bχ2 test, cFisher’s exact test
*585 women were aged ≤45 years, 7 were excluded from the analysis due to lack of information on intent to vaccinate themselves
**Women that did not answer the question were not included in the analysis
Boldface reflects statistical significance
Table 3 Women’s knowledge about HPV and cervical cancer after intervention by education levels and age
Item Years of Education Age
All ≤9 years >9 years ≤45 years >45 years
n (%) n (%) n (%) P n (%) n (%) P
Have you ever heard of HPV(N = 913)
Yes 539 (59.0) 437 (56.8) 102 (71.3) 0.001b 386 (66.0) 153 (46.6) <0.001b
No 374 (41.0) 333 (43.2) 41 (28.7) 199 (34.0) 175 (53.4)
Total 913 770 143 585 328
When HPV is mentioned, you will firstly think of(N = 539)
STD 58 (9.6) 44 (9.1) 14 (11.4) <0.001c 41 (9.6) 17 (9.6) <0.001b
Genital Warts 30 (5.0) 20 (4.1) 10 (8.2) 21 (4.9) 9 (5.1)
Cervical cancer 365 (60.3) 280 (58.0) 85 (69.7) 282 (65.7) 83 (47.2)
AIDS 23 (3.8) 19 (3.9) 4 (3.3) 16 (3.7) 7 (4.0)
Have no idea about HPV 129 (21.3) 120 (24.9) 9 (7.4) 69 (16.1) 60 (34.1)
Total 605 483 122 429 176
Have you ever heard of cervical cancer(N = 913)
Yes 814 (89.2) 676 (87.8) 138 (96.5) 0.011b 532 (92.8) 282 (82.9) <0.001b
No 99 (10.8) 94 (12.2) 5 (3.5) 41 (7.2) 58 (17.1)
Total 913 770 143 573 340
Do you know that cervical cancer is early detectable and treatable? (N = 814)
Yes 646 (79.4) 518 (76.6) 128 (92.8) <0.001b 442 (81.4) 204 (75.3) 0.042b
No 168 (20.6) 158 (23.4) 10 (7.3) 101 (18.6) 67 (24.7)
Total 814 676 138 543 271
bχ2 test, cFisher’s exact test
Boldface reflects statistical significance
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[10, 13–16], however, no previous studies have examined
how this ‘low awareness’ can be changed. The latter is
especially important given HPV infection is more preva-
lent among women living in rural areas of China [5] and
cervical cancer rates are over represented [17, 18]. Al-
though the Chinese government has initiated the first
step in controlling cervical cancer in rural China [5],
lack of knowledge of risk factors may become the barrier
to utilization of this service [19]. As well, poor under-
standing of the risks and consequences of HPV infection
has been reported as a potential barrier to the wide im-
plementation of HPV vaccination [20–23]. Therefore an
intervention to increase women’s knowledge about HPV
and cervical cancer is an essential component of any
comprehensive cervical cancer control program.
Based on previous findings that hospital based lectures
and suggestions from doctors and nurses were important
in influencing decisions about being vaccinated in both
rural and metropolitan areas [10], we evaluated the short-
term effectiveness of a hospital based local health provider
oriented lecture in changing local women’s awareness and
attitudes toward HPV and its vaccines. In this present
study, we found that women’s awareness both on HPV
and cervical cancer changed notably especially regarding
HPV immediately following the group education. Al-
though there is no comparative data available within
China, several studies from outside of China have investi-
gated the effectiveness of educational interventions of
varying duration, using various methods aiming at similar
goals and found that education intervention was associ-
ated with increased HPV-related knowledge [24–28]. This
study confirms that the short-term effectiveness of a one-
time brief group education intervention provided in a
hospital environment appears to be valid in raising aware-
ness among Chinese women from rural China, where the
majority of women have less than 9 years of education
(middle school).
Immediately after the educational intervention,
women’s awareness of ever heard of HPV increased
from 5.9 % to 59 %, however, 41 % of them still re-
ported that they had never heard of HPV. The reason
was possibly because that 86.6 % of women in this
population received middle school or less education,
suggesting that they did not have a chance to learn
English. In our intervention, HPV was expressed in
both English as ‘HPV’ and in Chinese as ‘Ren Ru Tou
Liu Bing Du’, however, in our questionnaire, it was
written only in English and asked by using the Eng-
lish term. This may result in the situation that
women were unaware of the English term ‘HPV’ even
immediately after the intervention. This should also
be considered in the future studies and the question
should be asked by using both the English term as
well as the Chinese term.
Another possibility might be that women at this
education level were not very interested in a PPT
oriented education, and some of them were absent
minded during the intervention, a more easy and
interesting way to conduct such intervention should
be considered among women that were less
educated.
Compared with the very low baseline awareness of
HPV, the acceptability of vaccination seemed to be
high at baseline. Although increases were also ob-
served in women’s attitudes toward HPV vaccination
after education, the net change was not as significant
Table 5 Changes in awareness and attitudes towards HPV and its vaccines
Pre-Intervention Post -Intervention Change P value
Count Percent (%) Count Percent (%) Percentage point difference
Have you ever heard of HPV (n = 913)
Yes 54 5.9 539 59.0 53.1 <0.001b
No 859 94.1 374 41.0
Have you ever heard of cervical cancer (n = 913)
Yes 575 63.0 814 89.2 26.2 <0.001b
No 338 37.0 99 10.8
Are you willing to vaccinate your daughter(s)(n = 631**)
Yes 523 82.9 555 88.0 5.1 0.011b
No 108 17.1 76 12.0
Are you willing to vaccinate yourself(n = 571***)
Yes 468 82.0 508 89.0 7.0 0.001b
No 103 18.0 63 11.0
b χ2 test
**5 women were excluded from the analysis due to lack of pre-educational information
***14 women were excluded from the analysis. 12 were due to lack of pre-educational information and 2 were due to lack of post-educational information
Boldface reflects statistical significance
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as the degree of change in women’s awareness of
HPV. The high acceptability of HPV vaccines have
been reported both in developing [10, 16] and devel-
oped countries [29–31]. Our study results suggested
that the attitudes toward HPV vaccination may not
simply rely on women’s awareness of HPV. Simply
educating women about HPV and HPV vaccines may
not be sufficient to influence their attitudes, as atti-
tudes may be driven by other, non-information-based
preferences. As ‘I don’t think vaccination works’ and
‘I have no risk’ were listed as the two primary reasons
for unwillingness to be vaccinated, more information
about the efficacy of HPV vaccines and the HPV
prevalence especially in high risk areas should be pre-
sented to women during the educational intervention
in the future.
In order to guarantee the flow of the cervical cancer
screening process, the baseline specific knowledge of
HPV (e.g. the risk of HPV, its link between cervical can-
cer etc.) and its related diseases were not examined,
however, the previous study indicated poor specific
knowledge about HPV especially among rural Chinese
women [10]. A study from the U.S has also reported that
few women have heard of HPV, and did not always
understand the link between cervical cancer and HPV
despite the media oriented education campaign carried
out prior to and after the availability of a quadrivalent
prophylactic vaccine in the U.S in 2006 [32]. In some
cases the participants were taken aback by the link be-
tween HPV and cervical cancer and had difficulty believ-
ing the link existed [32, 33]. Our study found that after
the group education, more than 60 % of women knew
that HPV is related to cervical cancer, whereas, only 5 %
knew the relationship between HPV and genital warts,
suggesting that intervention may be effective in increas-
ing women’s specific knowledge of HPV related diseases,
especially the most serious outcome of developing cer-
vical cancer. More should be done to increase women’s
knowledge regarding the link between HPV and genital
warts if a widespread educational campaign is carried
out in the future in mainland China.
Studies illustrated that greater knowledge about HPV
may be associated with greater vaccine acceptability
[31–39] and that poor knowledge about HPV and HPV
vaccination have direct implications for women’s partici-
pation in cervical screening [7, 8]. Although the effect-
iveness of hospital based group education on HPV and
cervical cancer awareness was observed in our study,
continuous education that is incorporated into health-
education from early childhood would be the most ef-
fective measure to help prevent cervical cancer [9, 40].
Some other educational intervention studies suggested
that the efficacy of interventions depends on their dur-
ation to a large extent and also requires regular ‘booster’
sessions [9, 41, 42] On the other hand, when designing
HPV-focused interventions, pooled efforts should be
considered not only from the health care providers but
also from the school teachers, the parents,the public
media and the government to achieve effective results
[43]. Advantages of such brief educational interventions
include that they are inexpensive and could be easily con-
ducted in the health care environment [44, 45], which
make it more feasible and realistic in low resource set-
tings where health care resources are limited.
There are several limitations of the study that need
to be considered. The study was undertaken in one
cervical cancer high risk rural county and may not
represent the general Chinese population. The lack of
a matched control group weakens the ability to assess
the effectiveness of the reported intervention. In
addition, the short term effectiveness does not neces-
sarily guarantee a long term impact, and a follow up
study with monthly intervals was not conducted to
evaluate the duration of effect as well as to help de-
cide the interval for a ‘booster’ session in future edu-
cation campaigns. Finally, the strongest measure of
the effectiveness of such an intervention would be as-
sociations with long-term outcomes such as decrease
in cervical cancer incidence and mortality [9], how-
ever this was beyond the scope of our study.
One of the major strengths of the present study is that
this is the first study to evaluate a simple method to a
conduct hospital based group education to change
women’s knowledge and attitudes toward HPV and its
vaccines in China. Additionally, the relatively large sam-
ple size renders the results valid for assessing the short-
term effectiveness of the reported program and useful
for developing further educational interventions.
Conclusions
In conclusion, this is the first intervention study on
changing rural Chinese women’s knowledge and atti-
tudes toward HPV and its vaccines. Our results confirm
that a brief, hospital-based educational intervention is
feasible to conduct in low resource settings and is ap-
propriate in increasing awareness and acceptability, al-
though the observed impact on attitudes towards
prevention was less compared with the impact in HPV
awareness. On the basis of our results, education cam-
paigns, particularly targeting women with limited educa-
tion and less access to public media or other educational
channels are needed in the near future, to improve
knowledge regarding HPV in the general population. A
multi-center nation-wide randomized trial to test the
intervention in both rural and urban Chinese women
with follow-up evaluation would build upon and
broaden the impact of this study.
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